ConductScience.org, home

Paper32962018

Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs.

Herceg V and 4 others. Molecules, 2020. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs. Papers, record 32962018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32962018

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs.
PubMed
Journal
Molecules
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.43
iCite
Revised in PubMed
2021-03-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Herceg VViktorija
2Bouilloux JJordan
3Janikowska KKarolina
4Allémann EEric
5Lange NNorberthttps://orcid.org/0000-0002-1087-1032

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cathepsin BMajor topic
Peptides, CyclicMajor topic
ProdrugsMajor topic
Amino Acid Sequence
Antibiotics, Antineoplastic
Cell Line, Tumor
Cell Membrane Permeability
Cell Survival
Click Chemistry
Doxorubicin
G2 Phase Cell Cycle Checkpoints
Humans
Polyethylene Glycols
Solubility

Source PubMed

Download CSV of topics

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116982417Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.Neuron2006https://conductscience.org/library/papers/16982417PubMed
216688341Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.Org Biomol Chem2006https://conductscience.org/library/papers/16688341PubMed
31318169Doxorubicin inhibits human DNA topoisomerase I.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1318169PubMed
426597527Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.Nat Rev Cancer2015https://conductscience.org/library/papers/26597527PubMed
527215466Engineering a 3D microfluidic culture platform for tumor-treating field application.Sci Rep2016https://conductscience.org/library/papers/27215466PubMed
618325618Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences.J Control Release2008https://conductscience.org/library/papers/18325618PubMed
77370266The interaction of daunorubicin and doxorubicin with DNA and chromatin.Biochim Biophys Acta1980https://conductscience.org/library/papers/7370266PubMed
81303755Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design.Protein Sci1992https://conductscience.org/library/papers/1303755PubMed
98392002
Doxorubicin-induced oxygen free radical formation in sensitive and doxorubicin-resistant variants of rat glioblastoma cell lines [corrected and republished erratum originally printed in FEBS Lett 1993 May 17;322(3):295-8].
FEBS Lett1993https://conductscience.org/library/papers/8392002PubMed
1015026265Cysteine proteases as disease markers.Clin Chim Acta2004https://conductscience.org/library/papers/15026265PubMed
1119109663Targeted delivery of activatable fluorescent pro-apoptotic peptide into live cells.Org Biomol Chem2009https://conductscience.org/library/papers/19109663PubMed
1210699287Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.J Control Release2000https://conductscience.org/library/papers/10699287PubMed
1316526790Chemoselectively addressable template: a valuable tool for the engineering of molecular conjugates.J Org Chem2006https://conductscience.org/library/papers/16526790PubMed
1417869367Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells.J Control Release2007https://conductscience.org/library/papers/17869367PubMed
1520638475Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation.Eur J Pharm Biopharm2010https://conductscience.org/library/papers/20638475PubMed
169973309Role of iron in anthracycline cardiotoxicity: new tunes for an old song?FASEB J1999https://conductscience.org/library/papers/9973309PubMed
179700924Deciphering the fluorescence signature of daunomycin and doxorubicin.Biophys Chem1998https://conductscience.org/library/papers/9700924PubMed
1824748018Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment.Curr Treat Options Cardiovasc Med2014https://conductscience.org/library/papers/24748018PubMed
1923278683Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.J Pharm Pharmacol2013https://conductscience.org/library/papers/23278683PubMed
2020835451Application of click-click chemistry to the synthesis of new multivalent RGD conjugates.Org Biomol Chem2010https://conductscience.org/library/papers/20835451PubMed

See all 48 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
40343561Cathepsin B in urological tumors: unraveling its role and therapeutic potential.Discov Oncol2025https://conductscience.org/library/papers/40343561PubMed
37724108Development of stimuli responsive polymeric nanomedicines modulating tumor microenvironment for improved cancer therapy.Med Rev (2021)2023https://conductscience.org/library/papers/37724108PubMed
37576397The Role of Cathepsin B in Pathophysiologies of Non-tumor and Tumor tissues: A Systematic Review.J Cancer2023https://conductscience.org/library/papers/37576397PubMed
35631388Cathepsin B-Cleavable Polymeric Photosensitizer Prodrug for Selective Photodynamic Therapy: In Vitro Studies.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35631388PubMed
34684822Double-PEGylated Cyclopeptidic Photosensitizer Prodrug Improves Drug Uptake from In Vitro to Hen's Egg Chorioallantoic Membrane Model.Molecules2021https://conductscience.org/library/papers/34684822PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTSB1508PubTator's text mininghttps://conductscience.org/library/genes/1508NCBI Gene
CYP1A21544PubTator's text mininghttps://conductscience.org/library/genes/1544NCBI Gene
CYP24A11591PubTator's text mininghttps://conductscience.org/library/genes/1591NCBI Gene
TOP2A7153PubTator's text mininghttps://conductscience.org/library/genes/7153NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32962018

GET https://conductscience.org/api/papers/v1/32962018/references?page=2